This is an exciting time in the world of drug discovery. We are in the midst of shaping a new future, with externalization and collaboration at the core of the business and research models for a growing number of companies. At Beryllium, our goal is to combine our expertise in structure-guided drug discovery with insights from functional biology to help our partners advance their research projects.
Akin to the pure, elemental vison of our name, we approach all of our partnerships with a keen focus on clarity and interaction transparency. Our aim is to build long-term partnerships with our clients. Thus, our success relies, not just on the success of the science, but also on the success of the execution of the project. We want our partners to think of us as extensions to their teams and not as “an external group we have a TC with once a week.”
Continue reading at the CORE Informatics blog